ntagi
NTAGI to discuss India’s first mRNA COVID vaccine data-
By Express News Service NEW DELHI: The National Technical Advisory Group on Immunisation’s (NTAGI) Covid working group is expected to ...
NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years-
By PTI NEW DELHI: The NTAGI’s Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for ...
NTAGI to review trial data on Serum Institute’s qHPV vaccine against cervical cancer-
By PTI NEW DELHI: The government advisory panel NTAGI is likely to review on June 28 trial data on India’s ...
NTAGI sub panel recommends reducing Covid booster dose gap to six months-
By Express News Service NEW DELHI: A panel of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended ...
NTAGI members agree on reducing Covid booster dose gap to six months; discuss monkeypox-
By PTI NEW DELHI: Members of the government advisory panel NTAGI on Thursday agreed on reducing the gap between the ...
NTAGI endorses precaution dose before nine-month waiting period for those travelling abroad: Sources
However, no recommendation as of now has been made by the National Technical Advisory Group on Immunisation (NTAGI) over reducing ...
Vaccines for kids below 12 years soon? Covid-19 working group of NTAGI to review data-
Express News Service NEW DELHI: The Covid-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will be ...
1st dose to be given as booster to those vaccinated with Sputnik V, NTAGI recommends-
By PTI NEW DELHI: The first dose of Sputnik V vaccine can be administered as the precaution dose to all ...
Second Covishield dose can be given between 8-16 weeks after first: NTAGI
The NTAGI has not yet suggested any change in the schedule of Bharat Biotech's Covaxin, whose second dose is administered 28 ...
NTAGI to consider administering ‘additional’ dose of Covid vaccine to immunocompromised people-
By PTI NEW DELHI: The issue of administering ‘additional’ dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon ...
